Related Experiment Video
Updated: Jun 7, 2026
08:01
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Genetic basis of thrombosis
Valeria Bafunno1, Maurizio Margaglione
1Genetica Medica, Dipartimento di Scienze Biomediche, Università degli Studi di Foggia, Foggia, Italy.
Clinical Chemistry and Laboratory Medicine
|November 2, 2010
Summary
Genetic factors significantly contribute to venous thrombosis (VT), a complex disorder involving blood clots. Research identifies specific gene mutations increasing VT risk, highlighting the need for further genetic investigation.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Venous thrombosis (VT) is a common, serious condition caused by blood clots in veins.
- Both environmental factors and genetic predisposition contribute to VT development.
- VT is considered a complex common disease, influenced by multiple genetic and environmental factors.
Purpose of the Study:
- To investigate the role of genetic risk factors in triggering thrombotic events.
- To identify genetic entities that increase the risk of VT.
- To explore genetic variations in hemostatic and anticoagulant pathways associated with VT.
Main Methods:
- Review of genetic studies on VT, including family studies and case-control association studies.
- Analysis of mutations in natural anticoagulants (antithrombin, protein C, protein S) and procoagulant factors (FV Leiden, prothrombin G20210A).
- Evaluation of genetic variations in FXIII, FIX, fibrinogen genes, and genes encoding anticoagulant pathway proteins.
- Inclusion of genome-wide association studies (GWAS) investigating single nucleotide polymorphisms (SNPs) related to VT risk.
Main Results:
- Identified loss-of-function mutations in natural anticoagulants and gain-of-function mutations in procoagulant factors as causes of VT.
- Observed a high incidence of specific mutations in Caucasian populations, shifting research focus.
- Investigated numerous candidate genes and genetic variations, including SNPs, associated with VT risk.
Conclusions:
- Genetic factors, particularly those affecting the hemostatic system, play a crucial role in VT.
- Further research is necessary to uncover additional genetic causes of thrombosis.
- Understanding the functional molecular mechanisms underlying genetic predisposition to VT requires continued investigation.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...